Tris(hydroxymethyl)nitromethane
Common Name: |
Tris(hydroxymethyl)nitromethane |
IUPAC Name: |
2-(hydroxymethyl)-2-nitropropane-1,3-diol |
Molecular Formula: |
C4H9NO5 |
SMILES: |
C(C(CO)(CO)[N+](=O)[O-])O |
Inchi: |
1S/C4H9NO5/c6-1-4(2-7,3-8)5(9)10/h6-8H,1-3H2 |
Inchi Key: |
OLQJQHSAWMFDJE-UHFFFAOYSA-N |
Cas No: |
126-11-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
4 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
3 |
Name |
Value |
Molecular Weight (g/mol) |
151.12 |
Mass (g/mol) |
151.048 |
Molar Refractivity |
32.97 |
Net Charge |
|
HBD |
3 |
HBA |
5 |
Rt Bonds |
4 |
Rings |
|
TPSA |
106.51 |
Hetero Atoms |
6 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
165 |
Boiling Point (°C@760.00mm Hg) |
445.6 |
Vapor Pressure (mmHg@25.00 °C) |
3.2 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
-2.021 |
iLOGP |
0.05 |
XLOGP3 |
-2.17 |
WLOGP |
-2.02 |
MLOGP |
-2.41 |
ESOL Log S |
0.85 |
ESOL Solubility (mg/ml) |
1080 |
ESOL Solubility (mol/l) |
7.15 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
0.46 |
Ali Solubility (mg/ml) |
440 |
Ali Solubility (mol/l) |
2.91 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
1.22 |
Silicos-IT Solubility (mg/ml) |
2500 |
Silicos-IT Solubility (mol/l) |
16.5 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-8.76 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.198 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.148 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |